SCHEMBL20194205

SCHEMBL20194205

CC(=N)SC(=N)c1cccc(N/C(=N/C=N)c2[nH]ccc2CN2CC(N)C2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20194187 0.92 CCR3 (0.34) —
SCHEMBL20194212 0.90 — —
SCHEMBL20194172 0.90 AAK1 (0.30) —
SCHEMBL20194162 0.83 F10 (0.34) —
SCHEMBL20194226 0.83 AAK1 (0.33) —
SCHEMBL20194213 0.81 AAK1 (0.31) —
SCHEMBL20194179 0.80 F10 (0.44) —
SCHEMBL20194228 0.79 F10 (0.34) —
SCHEMBL20194170 0.77 F10 (0.37) —
SCHEMBL20194185 0.77 F10 (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3054955-B1 PYRROLOTRIAZINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-05-30 — — EP disclosed
Send feedback